Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer

Conclusions
SNORA42 appears to be a novel oncogene and could serve as a promising predictive biomarker for recurrence and prognosis in patients with CRC.

Source: Gut - December 6, 2016 Category: Gastroenterology Authors: Okugawa, Y., Toiyama, Y., Toden, S., Mitoma, H., Nagasaka, T., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., Goel, A. Tags: Press releases, Colon cancer Source Type: research